BAL protein profiles specific of different interstitial lung diseases

E. Bargagli, C. Landi, D. Bennett, P. Di Sipio, L. Bini, P. Rottoli (Italy)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session: Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Session type: Thematic Poster Session
Number: 712
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Bargagli, C. Landi, D. Bennett, P. Di Sipio, L. Bini, P. Rottoli (Italy). BAL protein profiles specific of different interstitial lung diseases. Eur Respir J 2012; 40: Suppl. 56, 712

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs.
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018


Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009


The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009

Carbonylated proteins in BAL of patients with interstititial lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005

Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Analysis of antioxidant proteins and oxidized proteins in BAL of patients with interstitial lung diseases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004

Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002

Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012

HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

Role of BALF in differential diagnosis of smoking related interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007



T-cell cytokine pattern in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 173s
Year: 2002

Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010